Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
27,223 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Bitcoin holds near $71,000 as geopolitical risk cools, yet a raft of macro factors and an ETF decision window keep th...
Bitcoin resumes strength amid a broader risk-off backdrop for gold. The bitcoin resurgence faces a critical test near...
A Pantera report shows most tokenized assets sit as wrappers rather than native on-chain instruments, signaling a cau...
Joby Aviation reports modest quarterly revenue gains and robust cash reserves while advancing certification and inter...
A leading XRP analyst lays out three bullish paths for XRP, each signaling multi-fold gains as crypto markets re-pric...
SanDisk, Micron and Western Digital nosedived as investors cash in after a rapid AI memory rally, signaling a pause i...
The Senate Banking Committee advanced the Digital Asset Clarity Act on May 14, 2026, triggering an immediate rally in...
Geopolitics in the Gulf is shifting fast. Qatar eyes a $1 billion missiles package from BAE Systems, a move that coul...
Shopify beat expectations with robust 2025 results, while Amazon posted strong 2026 numbers, underscoring a clear spl...
Zcash (ZEC) rose 27% in the last seven days, lifting its market profile as investors weigh a path into the crypto mar...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...